蛋白質表現市場－全球產業規模、佔有率、趨勢、機會和預測，按表達系統、產品、最終用戶、地區和競爭格局分類，2020-2030年預測

全球蛋白質表現市場規模將從2024年的39億美元成長到2030年的68.3億美元，複合年成長率達9.80%。蛋白質表現是指在活細胞內將遺傳指令轉化為功能性蛋白質的複雜生物學機制，是生物學研究、藥物發現和生物製藥生產的重要方法。市場成長的主要驅動力是全球對用於治療用途（包括先進疫苗和單株抗體的開發）的重組蛋白的需求不斷成長。

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球蛋白質表現市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依表現系統（原核生物、哺乳動物細胞、昆蟲細胞、酵母菌、其他）
  • 依產品分類（試劑、感受態細胞、表現載體、服務、儀器）
  • 按最終用戶分類（製藥和生物技術公司、學術研究機構、合約研究機構、其他）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美蛋白質表現市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲蛋白質表現市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區蛋白質表現市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲蛋白質表現市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美蛋白質表現市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最新進展

第13章：全球蛋白質表現市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• New England BioLabs, Inc.
• Promega Corporation
• QIAGEN GmbH
• Takara Bio, Inc.
• Oxford Expression Technologies Ltd
• LGC Genomics Limited

第16章：策略建議

第17章調查會社について,免責事項

The Global Protein Expression Market will grow from USD 3.90 Billion in 2024 to USD 6.83 Billion by 2030 at a 9.80% CAGR. Protein expression describes the complex biological mechanisms by which genetic instructions are converted into functional proteins within living cells, constituting an essential methodology for biological research, drug discovery, and biopharmaceutical manufacturing. The market's growth is primarily fueled by the increasing global demand for recombinant proteins for therapeutic applications, including the development of advanced vaccines and monoclonal antibodies.

Key Market Drivers

The global protein expression market is significantly influenced by the increasing demand for biologics and protein therapeutics, which directly drives the need for sophisticated protein production capabilities. Biologics, encompassing monoclonal antibodies, advanced vaccines, and gene therapies, offer highly specific and effective treatment options for a broad spectrum of complex diseases. The consistent expansion in the development and manufacturing of these therapeutics mandates efficient and scalable protein expression systems. According to DCAT Value Chain Insights, in 2024, the FDA's Center for Drug Evaluation and Research approved 16 biological therapeutics, representing 32% of new drug approvals, highlighting the sustained output from this critical sector.

Key Market Challenges

The substantial costs associated with advanced expression systems and specialized reagents present a significant impediment to the growth of the global protein expression market. The financial outlay required for procuring, maintaining, and operating these sophisticated technologies, along with the recurring expense of highly specific reagents, creates a notable barrier to entry. This directly constrains smaller research institutions, emerging biotechnology companies, and academic laboratories from fully leveraging protein expression capabilities due to budget limitations, thereby impeding wider adoption across diverse research and industrial settings.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning for Expression Optimization significantly influences the global protein expression market by offering enhanced efficiency and predictive capabilities. These advanced computational methods enable researchers to precisely predict optimal protein expression conditions and design more effective protein constructs, accelerating drug candidate identification. According to a November 2024 report by the Information Technology and Innovation Foundation, AI has the potential to transform drug development, potentially reducing timelines by approximately half. This technological shift facilitates faster cycles and improved success rates in producing complex proteins. For instance, a September 2024 news release from the University of Texas at Austin detailed their team receiving nearly $2.5 million in grant funding for applying AI in protein engineering research for vaccine development.

Key Market Players

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• New England BioLabs, Inc.
• Promega Corporation
• QIAGEN GmbH
• Takara Bio, Inc.
• Oxford Expression Technologies Ltd
• LGC Genomics Limited

Report Scope:

In this report, the Global Protein Expression Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Expression Market, By Expression System:

• Prokaryotic
• Mammalian Cell
• Insect Cell
• Yeast
• Others

Protein Expression Market, By Product:

• Reagents
• Competent Cells
• Expression Vectors
• Services
• Instruments

Protein Expression Market, By End user:

• Pharmaceutical and Biotechnological Companies
• Academic Research
• Contract research organizations
• Others

Protein Expression Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Protein Expression Market.

Available Customizations:

Global Protein Expression Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Expression Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Expression System (Prokaryotic, Mammalian Cell, Insect Cell, Yeast, Others)
  • 5.2.2. By Product (Reagents, Competent Cells, Expression Vectors, Services, Instruments)
  • 5.2.3. By End user (Pharmaceutical and Biotechnological Companies, Academic Research, Contract research organizations, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Protein Expression Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Expression System
  • 6.2.2. By Product
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Protein Expression Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Expression System
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End user
  • 6.3.2. Canada Protein Expression Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Expression System
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End user
  • 6.3.3. Mexico Protein Expression Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Expression System
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End user

7. Europe Protein Expression Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Expression System
  • 7.2.2. By Product
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Protein Expression Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Expression System
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End user
  • 7.3.2. France Protein Expression Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Expression System
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End user
  • 7.3.3. United Kingdom Protein Expression Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Expression System
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End user
  • 7.3.4. Italy Protein Expression Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Expression System
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Protein Expression Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Expression System
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End user

8. Asia Pacific Protein Expression Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Expression System
  • 8.2.2. By Product
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Protein Expression Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Expression System
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End user
  • 8.3.2. India Protein Expression Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Expression System
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End user
  • 8.3.3. Japan Protein Expression Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Expression System
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End user
  • 8.3.4. South Korea Protein Expression Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Expression System
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Protein Expression Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Expression System
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End user

9. Middle East & Africa Protein Expression Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Expression System
  • 9.2.2. By Product
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Protein Expression Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Expression System
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End user
  • 9.3.2. UAE Protein Expression Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Expression System
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End user
  • 9.3.3. South Africa Protein Expression Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Expression System
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End user

10. South America Protein Expression Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Expression System
  • 10.2.2. By Product
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Protein Expression Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Expression System
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End user
  • 10.3.2. Colombia Protein Expression Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Expression System
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End user
  • 10.3.3. Argentina Protein Expression Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Expression System
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Protein Expression Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Agilent Technologies, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bio-Rad Laboratories, Inc.
• 15.3. Thermo Fisher Scientific, Inc.
• 15.4. Merck KGaA
• 15.5. New England BioLabs, Inc.
• 15.6. Promega Corporation
• 15.7. QIAGEN GmbH
• 15.8. Takara Bio, Inc.
• 15.9. Oxford Expression Technologies Ltd
• 15.10. LGC Genomics Limited

16. Strategic Recommendations

17. About Us & Disclaimer